These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9300352)

  • 1. Experimental design and estimation of parameters in complex radioligand binding systems.
    Staschen CM; Homer LD
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):589-609. PubMed ID: 9300352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
    Karlsson MO; Neil A
    Mol Pharmacol; 1989 Jan; 35(1):59-66. PubMed ID: 2913484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifiability analysis of second-order systems.
    Scheibe PO
    Nucl Med Biol; 2003 Nov; 30(8):827-32. PubMed ID: 14698786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model testing in radioligand/receptor interaction by Monte Carlo simulation.
    Bürgisser E
    J Recept Res; 1983; 3(1-2):261-81. PubMed ID: 6304303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.
    Pietra D; Borghini A; Breschi MC; Bianucci AM
    J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple.
    Krohn KA; Link JM
    Nucl Med Biol; 2003 Nov; 30(8):819-26. PubMed ID: 14698785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography.
    Delforge J; Syrota A; Mazoyer BM
    Phys Med Biol; 1989 Apr; 34(4):419-35. PubMed ID: 2540497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent competitive inhibition of radioligand binding to receptors: experimental and theoretical considerations in the analysis of equilibrium binding data.
    Tomlinson G; Hnatowich MR
    J Recept Res; 1988; 8(6):809-30. PubMed ID: 3193403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Optimal' designs for drug, neurotransmitter and hormone receptor assays.
    Dunn G
    Stat Med; 1988 Jul; 7(7):805-15. PubMed ID: 2841743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of contamination on radioligand binding parameters.
    Lazareno S; Birdsall NJ
    Trends Pharmacol Sci; 2000 Feb; 21(2):57-60. PubMed ID: 10664609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioligand Binding Assays for Determining Dissociation Constants of Phytohormone Receptors.
    Hellmuth A; Calderón Villalobos LI
    Methods Mol Biol; 2016; 1450():23-34. PubMed ID: 27424743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing radioligand binding data.
    Motulsky H; Neubig R
    Curr Protoc Protein Sci; 2001 May; Appendix 3():Appendix 3H. PubMed ID: 18429075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.
    Casadó-Anguera V; Moreno E; Mallol J; Ferré S; Canela EI; Cortés A; Casadó V
    Pharmacol Res; 2019 Jan; 139():337-347. PubMed ID: 30472462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and rapid orientation procedure for the estimation of affinities (1/Kd) and maximum binding capacities (Bmax) of ligand binding to two receptor subpopulations.
    Hynie S; Bojar S; Klenerová V; Wenke M
    Physiol Bohemoslov; 1986; 35(4):299-307. PubMed ID: 3020601
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.